Michel Cuendet

9PUBLICATIONS
48CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsImmunogenetics (incl. genetic immunology)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 11, 2025
Sorafenib plus selective internal radiotherapy with <sup>90</sup>Y resin microspheres for the treatment of uveal melanoma with liver metastasis: a phase I trial.

Grégoire Berthod, Christophe Cisarovsky, Tatiana Petrova

|Oct 18, 2023
Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial.

André Manuel da Silva Lopes, Sara Colomer-Lahiguera, Célia Darnac

|Jun 17, 2023
Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapy.

Perrine Courlet, Daniel Abler, Monia Guidi

|May 05, 2023
Semiautomated Pipeline to Quantify Tumor Evolution From Real-World Positron Emission Tomography/Computed Tomography Imaging.

Daniel Abler, Perrine Courlet, Matthieu Dietz

|Jan 08, 2023
Estimated Costs of the Ipilimumab-Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma.

Bianca Gautron Moura, Camille L Gerard, Nathalie Testart

|Mar 10, 2022
Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma.

Veronica Aedo-Lopez, Camille L Gérard, Sarah Boughdad

Pageof 2

Frequent Collaborators

3 joint publications

John O Prior

2 joint publications

Daniel Abler

2 joint publications

Olivier Michielin

2 joint publications

Perrine Courlet